Individualizing colonoscopy screening by sex and race

Gastrointestinal Endoscopy

Volumn 70, Issue 1, 2009, Pages

  Lansdorp Vogelaar, Iris ^a   van Ballegooijen, Marjolein ^a   Zauber, Ann G ^a   Boer, Rob ^a   Wilschut, Janneke ^a   Winawer, Sidney J ^a   Habbema, J Dik F ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER RISK; CANCER SCREENING; CANCER STAGING; CANCER SURVIVAL; COHORT ANALYSIS; COLONOSCOPY; COLORECTAL CANCER; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; EUROPEAN AMERICAN; FEMALE; HEALTH CARE COST; HUMAN; LIFE EXPECTANCY; MAJOR CLINICAL STUDY; MALE; MEDICAL PRACTICE; PRACTICE GUIDELINE; PRIORITY JOURNAL; RACE DIFFERENCE; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE; UNITED STATES;

EID: 67549149024     PISSN: 00165107     EISSN: 10976779     Source Type: Journal    
DOI: 10.1016/j.gie.2008.08.040     Document Type: Article

References (77)

1. Winawer S., Fletcher R., Rex D., et al. Colorectal cancer screening and surveillance: clinical guidelines and rationale-update based on new evidence. Gastroenterology 124 (2003) 544-560
2. Levin B., Lieberman D.A., McFarland B., et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. CA Cancer J Clin 58 (2008) 130-160
3. Lieberman D. Race, gender, and colorectal cancer screening. Am J Gastroenterol 100 (2005) 2756-2758
4. Agrawal S., Bhupinderjit A., Bhutani M.S., et al. Colorectal cancer in African Americans. Am J Gastroenterol 100 (2005) 515-523 discussion 14
5. Ries L.A.G., Eisner M.P., Kosary C.L., et al. SEER cancer statistics review, 1975-2001. National Cancer Institute (2004). http://seer.cancer.gov/csr/1975_2001/ Accessed October 8, 2008
6. Goldie S.J. Chapter 15: Public health policy and cost-effectiveness analysis. J Natl Cancer Inst Monogr (2003) 102-110
7. Loeve F., Boer R., van Oortmarssen G.J., et al. The MISCAN-COLON simulation model for the evaluation of colorectal cancer screening. Comput Biomed Res 32 (1999) 13-33
8. Loeve F., Brown M.L., Boer R., et al. Endoscopic colorectal cancer screening: a cost-saving analysis. J Natl Cancer Inst 92 (2000) 557-563
9. Vogelaar I., van Ballegooijen M., Zauber A.G., et al. Model profiler of the MISCAN-Colon microsimulation model for colorectal cancer. Department of Public Health. Erasmus MC (2004). https://cisnet.flexkb.net/mp/pub/cisnet_colorectal_sloankettering_profil e.pdf Accessed October 8, 2008
10. Morson B. President's address. The polyp-cancer sequence in the large bowel. Proc R Soc Med 67 (1974) 451-457
11. Muto T., Bussey H.J., and Morson B.C. The evolution of cancer of the colon and rectum. Cancer 36 (1975) 2251-2270
12. van Rijn J.C., Reitsma J.B., Stoker J., et al. Polyp miss rate determined by tandem colonoscopy: a systematic review. Am J Gastroenterol 101 (2006) 343-350
13. Aslinia F., Uradomo L., Steele A., et al. Quality assessment of colonoscopic cecal intubation: an analysis of 6 years of continuous practice at a university hospital. Am J Gastroenterol 101 (2006) 721-731
14. Cotterill M., Gasparelli R., and Kirby E. Colorectal cancer detection in a rural community. Development of a colonoscopy screening program. Can Fam Physician 51 (2005) 1224-1228
15. Rex D.K., Bond J.H., Winawer S., et al. Quality in the technical performance of colonoscopy and the continuous quality improvement process for colonoscopy: recommendations of the U.S. Multi-Society Task Force on Colorectal Cancer. Am J Gastroenterol 97 (2002) 1296-1308
16. Levin T.R., Zhao W., Conell C., et al. Complications of colonoscopy in an integrated health care delivery system. Ann Intern Med 145 (2006) 880-886
17. Lieberman D.A., Weiss D.G., Bond J.H., et al. Use of colonoscopy to screen asymptomatic adults for colorectal cancer. Veterans Affairs Cooperative Study Group 380. N Engl J Med 343 (2000) 162-168
18. Pox C., Schmiegel W., and Classen M. Current status of screening colonoscopy in Europe and in the United States. Endoscopy 39 (2007) 168-173
19. Regula J., Rupinski M., Kraszewska E., et al. Colonoscopy in colorectal-cancer screening for detection of advanced neoplasia. N Engl J Med 355 (2006) 1863-1872
20. Jentschura D., Raute M., Winter J., et al. Complications in endoscopy of the lower gastrointestinal tract. Therapy and prognosis. Surg Endosc 8 (1994) 672-676
21. Koretz R.L. Malignant polyps: are they sheep in wolves' clothing?. Ann Intern Med 118 (1993) 63-68
22. DiSario J.A., Foutch P.G., Mai H.D., et al. Prevalence and malignant potential of colorectal polyps in asymptomatic, average-risk men. Am J Gastroenterol 86 (1991) 941-945
23. Johnson D.A., Gurney M.S., Volpe R.J., et al. A prospective study of the prevalence of colonic neoplasms in asymptomatic patients with an age-related risk. Am J Gastroenterol 85 (1990) 969-974
24. Lieberman D.A., and Smith F.W. Screening for colon malignancy with colonoscopy. Am J Gastroenterol 86 (1991) 946-951
25. Rex D.K., Lehman G.A., Hawes R.H., et al. Screening colonoscopy in asymptomatic average-risk persons with negative fecal occult blood tests. Gastroenterology 100 (1991) 64-67
26. Loeve F., Boer R., van Ballegooijen M., et al. Final report MISCAN-Colon microsimulation model for colorectal cancer. Rotterdam: Department of Public Health. Erasmus MC (1998)
27. Loeve F., Boer R., Zauber A.G., et al. National Polyp Study data: evidence for regression of adenomas. Int J Cancer 111 (2004) 633-639
28. Vogelaar I., van Ballegooijen M., Schrag D., et al. How much can current interventions reduce colorectal cancer mortality in the U.S.? Mortality projections for scenarios of risk-factor modification, screening, and treatment. Cancer 107 (2006) 1624-1633
29. U.S. interim projections by age, sex, race, and Hispanic origin, vol. 2005 (2004), U.S. Census Bureau, Washington DC
30. Hollingsworth B., Dawson P.J., and Maniadakis N. Efficiency measurement of health care: a review of non-parametric methods and applications. Health Care Manag Sci 2 (1999) 161-172
31. Johannesson M., and Weinstein M.C. On the decision rules of cost-effectiveness analysis. J Health Econ 12 (1993) 459-467
32. Winawer S.J., Zauber A.G., Fletcher R.H., et al. Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society. CA Cancer J Clin 56 (2006) 143-159 quiz 84-5
33. Zauber AG, Lansdorp-Vogelaar I, Wilschut J, et al. Cost-effectiveness of DNA stool testing to screen for colorectal cancer 2007. Available at:https://www.cms.hhs.gov/mcd/viewtechassess.asp?where=index&tid=52 . Accessed October 8, 2008
34. Yabroff K.R., Lamont E.B., Mariotto A., et al. Cost of care for elderly cancer patients in the United States. J Natl Cancer Inst 100 (2008) 630-641
35. In: Gold M.R.S.J., Russell L.B., and Weinstein M.G. (Eds). Cost-effectiveness in health and medicine (1996), Oxford University Press, New York
36. Anderson J.C., Gonzalez J.D., Messina C.R., et al. Factors that predict incomplete colonoscopy: thinner is not always better. Am J Gastroenterol 95 (2000) 2784-2787
37. Cotton P.B., Connor P., McGee D., et al. Colonoscopy: practice variation among 69 hospital-based endoscopists. Gastrointest Endosc 57 (2003) 352-357
38. Denis B., Weiss A.M., Peter A., et al. Quality assurance and gastrointestinal endoscopy: an audit of 500 colonoscopic procedures. Gastroenterol Clin Biol 28 (2004) 1245-1255
39. Harewood G.C. Relationship of colonoscopy completion rates and endoscopist features. Dig Dis Sci 50 (2005) 47-51
40. Harewood G.C., and Lieberman D.A. Colonoscopy practice patterns since introduction of medicare coverage for average-risk screening. Clin Gastroenterol Hepatol 2 (2004) 72-77
41. Schoenfeld P., Cash B., Flood A., et al. Colonoscopic screening of average-risk women for colorectal neoplasia. N Engl J Med 352 (2005) 2061-2068
42. Shah H.A., Paszat L.F., Saskin R., et al. Factors associated with incomplete colonoscopy: a population-based study. Gastroenterology 132 (2007) 2297-2303
43. Frazier A.L., Colditz G.A., Fuchs C.S., et al. Cost-effectiveness of screening for colorectal cancer in the general population. JAMA 284 (2000) 1954-1961
44. Khandker R.K., Dulski J.D., Kilpatrick J.B., et al. A decision model and cost-effectiveness analysis of colorectal cancer screening and surveillance guidelines for average-risk adults. Int J Technol Assess Health Care 16 (2000) 799-810
45. Pickhardt P.J., Hassan C., Laghi A., et al. Cost-effectiveness of colorectal cancer screening with computed tomography colonography: the impact of not reporting diminutive lesions. Cancer 109 (2007) 2213-2221
46. Ladabaum U., Chopra C.L., Huang G., et al. Aspirin as an adjunct to screening for prevention of sporadic colorectal cancer. A cost-effectiveness analysis. Ann Intern Med 135 (2001) 769-781
47. Ladabaum U., Song K., and Fendrick A.M. Colorectal neoplasia screening with virtual colonoscopy: when, at what cost, and with what national impact?. Clin Gastroenterol Hepatol 2 (2004) 554-563
48. Lieberman D.A. Cost-effectiveness model for colon cancer screening. Gastroenterology 109 (1995) 1781-1790
49. Ness R.M., Holmes A.M., Klein R., et al. Cost-utility of one-time colonoscopic screening for colorectal cancer at various ages. Am J Gastroenterol 95 (2000) 1800-1811
50. Sonnenberg A., and Delco F. Cost-effectiveness of a single colonoscopy in screening for colorectal cancer. Arch Intern Med 162 (2002) 163-168
51. Sonnenberg A., Delco F., and Bauerfeind P. Is virtual colonoscopy a cost-effective option to screen for colorectal cancer?. Am J Gastroenterol 94 (1999) 2268-2274
52. Sonnenberg A., Delco F., and Inadomi J.M. Cost-effectiveness of colonoscopy in screening for colorectal cancer. Ann Intern Med 133 (2000) 573-584
53. Vijan S., Hwang E.W., Hofer T.P., et al. Which colon cancer screening test? A comparison of costs, effectiveness, and compliance. Am J Med 111 (2001) 593-601
54. Vijan S., Hwang I., Inadomi J., et al. The cost-effectiveness of CT colonography in screening for colorectal neoplasia. Am J Gastroenterol 102 (2007) 380-390
55. Glick S., Wagner J.L., and Johnson C.D. Cost-effectiveness of double-contrast barium enema in screening for colorectal cancer. AJR Am J Roentgenol 170 (1998) 629-636
56. Briggs A.H., O'Brien B.J., and Blackhouse G. Thinking outside the box: recent advances in the analysis and presentation of uncertainty in cost-effectiveness studies. Annu Rev Public Health 23 (2002) 377-401
57. Theuer C.P., Taylor T.H., Brewster W.R., et al. Gender and race/ethnicity affect the cost-effectiveness of colorectal cancer screening. J Natl Med Assoc 98 (2006) 51-57
58. Theuer C.P., Wagner J.L., Taylor T.H., et al. Racial and ethnic colorectal cancer patterns affect the cost-effectiveness of colorectal cancer screening in the United States. Gastroenterology 120 (2001) 848-856
59. Meissner H.I., Breen N., Klabunde C.N., et al. Patterns of colorectal cancer screening uptake among men and women in the United States. Cancer Epidemiol Biomarkers Prev 15 (2006) 389-394
60. Kalow W. Pharmacogenetics and pharmacogenomics: origin, status, and the hope for personalized medicine. Pharmacogenomics J 6 (2006) 162-165
61. Abrahams E., Ginsburg G.S., and Silver M. The Personalized Medicine Coalition: goals and strategies. Am J Pharmacogenomics 5 (2005) 345-355
62. Lieberman D.A., Holub J., Eisen G., et al. Prevalence of polyps greater than 9 mm in a consortium of diverse clinical practice settings in the United States. Clin Gastroenterol Hepatol 3 (2005) 798-805
63. Chan A.T., Giovannucci E.L., Schernhammer E.S., et al. A prospective study of aspirin use and the risk for colorectal adenoma. Ann Intern Med 140 (2004) 157-166
64. Giovannucci E., Ascherio A., Rimm E.B., et al. Physical activity, obesity, and risk for colon cancer and adenoma in men. Ann Intern Med 122 (1995) 327-334
65. Giovannucci E., Colditz G.A., Stampfer M.J., et al. Physical activity, obesity, and risk of colorectal adenoma in women (United States). Cancer Causes Control 7 (1996) 253-263
66. Giovannucci E., Egan K.M., Hunter D.J., et al. Aspirin and the risk of colorectal cancer in women. N Engl J Med 333 (1995) 609-614
67. Giovannucci E., Stampfer M.J., Colditz G.A., et al. Multivitamin use, folate, and colon cancer in women in the Nurses' Health Study. Ann Intern Med 129 (1998) 517-524
68. Giovannucci E., Stampfer M.J., Colditz G.A., et al. Folate, methionine, and alcohol intake and risk of colorectal adenoma. J Natl Cancer Inst 85 (1993) 875-884
69. Taupin D., Chambers S.L., Corbett M., et al. Colonoscopic screening for colorectal cancer improves quality of life measures: a population-based screening study. Health Qual Life Outcomes 4 (2006) 82
70. Crimmins E.M., and Saito Y. Trends in healthy life expectancy in the United States, 1970-1990: gender, racial, and educational differences. Soc Sci Med 52 (2001) 1629-1641
71. Brenner H., Hoffmeister M., Arndt V., et al. Gender differences in colorectal cancer: implications for age at initiation of screening. Br J Cancer 96 (2007) 828-831
72. Imperiale T.F., Wagner D.R., Lin C.Y., et al. Using risk for advanced proximal colonic neoplasia to tailor endoscopic screening for colorectal cancer. Ann Intern Med 139 (2003) 959-965
73. Cancer facts and figures 2007. American Cancer Society (2007). http://www.cancer.org/downloads/STT/CAFF2007PWSecured.pdf Accessed October 8, 2008
74. Rex D.K., Johnson D.A., Lieberman D.A., et al. Colorectal cancer prevention 2000: screening recommendations of the American College of Gastroenterology. American College of Gastroenterology. Am J Gastroenterol 95 (2000) 868-877
75. Colorectal cancer facts and figures special edition 2005. American Cancer Society (2005). http://www.cancer.org/downloads/STT/CAFF2005CR4PWSecured.pdf Accessed October 8, 2008
76. Gyrd-Hansen D., Sogaard J., and Kronborg O. Analysis of screening data: colorectal cancer. Int J Epidemiol 26 (1997) 1172-1181
77. Hardcastle J.D., Chamberlain J.O., Robinson M.H., et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 348 (1996) 1472-1477